IGF-1 LR3

This engineered variant of insulin-like growth factor extends IGF-1's naturally brief activity period from minutes to hours through strategic amino acid modifications. Muscle physiology researchers have gravitated toward IGF-1 LR3 because it potentially offers more sustained anabolic signaling than native IGF-1. The peptide represents an attempt to harness IGF-1's growth-promoting effects while overcoming its rapid degradation in biological systems.

IGF-1 LR3 binds to IGF-1 receptors on muscle and other tissues, triggering a cascade of cellular growth signals including protein synthesis and cell division pathways. The 'LR3' modification prevents the peptide from binding to IGF binding proteins that normally inactivate IGF-1 within minutes, allowing it to circulate and remain active for significantly longer periods. This extended activity window theoretically means cells receive growth signals for hours rather than the brief bursts seen with natural IGF-1.